As previously announced, the employment term of Robert Cook, the Chief Financial Officer of CorMedix Inc. expired on January 31, 2020 and he has ceased to be company principal financial officer and principal accounting officer. Effective on that date, Khoso Baluch, the Chief Executive Officer of the company, will perform the functions of principal financial officer and principal accounting officer on an interim basis until the company appoints a new Chief Financial Officer. The company is engaged with a search firm to identify a new Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.12 USD | -1.54% | -0.97% | +36.17% |
May. 09 | Transcript : CorMedix Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.17% | 281M | |
+10.49% | 8.96B | |
-10.76% | 5.19B | |
+51.58% | 4.77B | |
+12.50% | 4.26B | |
-20.70% | 2.37B | |
+13.08% | 2.3B | |
-29.65% | 2.21B | |
+19.51% | 2.17B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix, Inc. Announces Management Changes